Ligand Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

Ligand Pharmaceuticals Incorporated

07/11/2024 14:32

* Ligand Pharmaceuticals Inc  LGND.OQ  reported quarterly
adjusted
earnings of $1.84​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of $1.02.  The mean expectation of eight analysts
for the quarter was for earnings of $1.35 per share. Wall Street
expected results to range from $1.17  to $1.68 per share.
    * Revenue rose 57.6% to $51.81 million from a year ago;
analysts
expected $40.65 million. 
    * Ligand Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 39 cents​.
    * The company reported a quarterly loss of $7.17 million.
    * Ligand Pharmaceuticals Inc shares had risen by 16.8% this
quarter and gained 63.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.8%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Ligand
Pharmaceuticals Inc is $129.00 
This summary was machine generated from LSEG data November 7 at
02:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      1.35           1.84           Beat
 Jun. 30 2024                     1.40           
 Mar. 31 2024      0.78           1.20           Beat
 Dec. 31 2023      0.66           1.38           Beat